159 related articles for article (PubMed ID: 26132566)
1. The Effect of Diagnostic Absorbed Doses from 131I on Human Thyrocytes in Vitro.
Adamczewski Z; Stasiołek M; Karwowski B; Dedecjus M; Orszulak-Michalak D; Merecz A; Śliwka PW; Puła B; Lewiński A
Int J Mol Sci; 2015 Jun; 16(7):14608-22. PubMed ID: 26132566
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells.
Lundh C; Lindencrona U; Postgård P; Carlsson T; Nilsson M; Forssell-Aronsson E
J Nucl Med; 2009 Jul; 50(7):1161-7. PubMed ID: 19525464
[TBL] [Abstract][Full Text] [Related]
3. The Molecular Effect of Diagnostic Absorbed Doses from
Stasiołek M; Adamczewski Z; Śliwka PW; Puła B; Karwowski B; Merecz-Sadowska A; Dedecjus M; Lewiński A
Molecules; 2017 Jun; 22(6):. PubMed ID: 28617334
[TBL] [Abstract][Full Text] [Related]
4. Reduced iodide transport (stunning) and DNA synthesis in thyrocytes exposed to low absorbed doses from 131I in vitro.
Lundh C; Nordén MM; Nilsson M; Forssell-Aronsson E
J Nucl Med; 2007 Mar; 48(3):481-6. PubMed ID: 17332627
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of the sodium/iodide symporter explains 131I-induced thyroid stunning.
Nordén MM; Larsson F; Tedelind S; Carlsson T; Lundh C; Forssell-Aronsson E; Nilsson M
Cancer Res; 2007 Aug; 67(15):7512-7. PubMed ID: 17671222
[TBL] [Abstract][Full Text] [Related]
6. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
[TBL] [Abstract][Full Text] [Related]
7. Thyroid stunning in vivo and in vitro.
Medvedec M
Nucl Med Commun; 2005 Aug; 26(8):731-5. PubMed ID: 16000993
[TBL] [Abstract][Full Text] [Related]
8. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
[TBL] [Abstract][Full Text] [Related]
9. Stunning of iodide transport by (131)I irradiation in cultured thyroid epithelial cells.
Postgård P; Himmelman J; Lindencrona U; Bhogal N; Wiberg D; Berg G; Jansson S; Nyström E; Forssell-Aronsson E; Nilsson M
J Nucl Med; 2002 Jun; 43(6):828-34. PubMed ID: 12050329
[TBL] [Abstract][Full Text] [Related]
10. ⁹⁹mTcO₄--, auger-mediated thyroid stunning: dosimetric requirements and associated molecular events.
Cambien B; Franken PR; Lamit A; Mauxion T; Richard-Fiardo P; Guglielmi J; Crescence L; Mari B; Pourcher T; Darcourt J; Bardiès M; Vassaux G
PLoS One; 2014; 9(3):e92729. PubMed ID: 24663284
[TBL] [Abstract][Full Text] [Related]
11. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
12. Does thyroid stunning exist? A model with benign thyroid disease.
Sabri O; Zimny M; Schreckenberger M; Meyer-Oelmann A; Reinartz P; Buell U
Eur J Nucl Med; 2000 Nov; 27(11):1591-7. PubMed ID: 11105814
[TBL] [Abstract][Full Text] [Related]
13. A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments.
Leger AF; Pellan M; Dagousset F; Chevalier A; Keller I; Clerc J
Br J Radiol; 2005 May; 78(929):428-32. PubMed ID: 15845937
[TBL] [Abstract][Full Text] [Related]
14. Impact of 131I diagnostic activities on the biokinetics of thyroid remnants.
Lassmann M; Luster M; Hänscheid H; Reiners C
J Nucl Med; 2004 Apr; 45(4):619-25. PubMed ID: 15073258
[TBL] [Abstract][Full Text] [Related]
15. Iodine‑131 metabolic radiotherapy leads to cell death and genomic alterations through NIS overexpression on cholangiocarcinoma.
Brito AF; Abrantes AM; Teixo R; Pires AS; Ribeiro AC; Ferreira RF; Mascarenhas A; Puga T; Laranjo M; Caramelo F; Boin I; Jefferson DM; Gonçalves C; Martins R; Tavares I; Ribeiro IP; Sarmento-Ribeiro AB; Carreira IM; Souza D; Tralhão JG; Botelho MF
Int J Oncol; 2020 Mar; 56(3):709-727. PubMed ID: 31922240
[TBL] [Abstract][Full Text] [Related]
16. The sodium-iodine symporter and the proton-pump inhibitors in - related to the side effects of- the treatment of thyroid cancer with iodine-131.
Sfakianakis G; Sfakianaki E
Hell J Nucl Med; 2007; 10(1):2-5. PubMed ID: 17450241
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the Role of Thyrotropin in the DNA Damage Response in Human Thyrocytes after 131I, γ Radiation and H2O2.
Kyrilli A; Gacquer D; Detours V; Lefort A; Libert F; Twyffels L; Van Den Eeckhaute L; Strickaert A; Maenhaut C; De Deken X; Dumont JE; Miot F; Corvilain B
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31701151
[TBL] [Abstract][Full Text] [Related]
18. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
[TBL] [Abstract][Full Text] [Related]
19. [99mTc reduces clonogenic survival after intracellular uptake in NIS-positive cells in vitro more than 131I].
Wendisch M; Freudenberg R; Drechsel J; Runge R; Wunderlich G; Kotzerke J
Nuklearmedizin; 2010; 49(4):154-60. PubMed ID: 20490428
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the cell death pathway and apoptosis-stunning effect relationship after low- and high-dose I-131 administrations in rat thyroid tissue.
Turgut B; Babul A; Ozdemir O; Erselcan T
Cancer Biother Radiopharm; 2006 Aug; 21(4):342-51. PubMed ID: 16999600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
